AR012437A1 - Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacion - Google Patents
Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacionInfo
- Publication number
- AR012437A1 AR012437A1 ARP980101734A ARP980101734A AR012437A1 AR 012437 A1 AR012437 A1 AR 012437A1 AR P980101734 A ARP980101734 A AR P980101734A AR P980101734 A ARP980101734 A AR P980101734A AR 012437 A1 AR012437 A1 AR 012437A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- manufacture
- preparation
- compounds
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Un compuesto de 4-aminopirido [2,3D]pirimidina 5,6,7-trisustituido o una sal o amida farmacéuticamente aceptable del mismo que tiene la formula (I),donde R1 y R2 son independienteente H, alquilo inferior, arilalquilo o acilo, pueden tomarseconj untamente con el átomo de nitrogeno al cual está unidos paraformar un anillo de 5 a 7 miembros que contiene opcionalmente 1,3 heteroátomos adicionales seleccionados de N, O o S; R3, R4 y R5 están independientementeseleccionados de alquiloinferior, alquenilo inferior, alquinilo inferior, cicloalquilo inferior, arilo, arilalquilo, heteroarilo o un grupo heterocíclicoindica que está presente opcionalmente un doble enlace; el uso de los mismos para la manufactura de unmedicamento util par a inhibir adenosina quinasa, unacomposicion farmacéutica que comprende una cantidad terapéuticamente eficaz de dichos compuestos en combinacion con un portador farmacéuticamente aceptable,eluso de los mismos para lamanufactura de un medicamento ut il para tratar isquemia cerebral, epilepsia, dolor, nocipercepcion, inflamacion y sepsis en unmamífero que necesita dicho tratamiento, procedimiento para su preparacion , compuestos intermediarios yprocedimiento para su preparacion,
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84348497A | 1997-04-16 | 1997-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR012437A1 true AR012437A1 (es) | 2000-10-18 |
Family
ID=25290123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980101734A AR012437A1 (es) | 1997-04-16 | 1998-04-15 | Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacion |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0975633A1 (es) |
JP (1) | JP2001520654A (es) |
KR (1) | KR20010006462A (es) |
CN (1) | CN1252069A (es) |
AR (1) | AR012437A1 (es) |
AU (1) | AU741033B2 (es) |
BG (1) | BG103853A (es) |
BR (1) | BR9809056A (es) |
CA (1) | CA2286592A1 (es) |
CO (1) | CO4940470A1 (es) |
HU (1) | HUP0001443A3 (es) |
IL (1) | IL131617A0 (es) |
NO (1) | NO995035L (es) |
NZ (1) | NZ337125A (es) |
PL (1) | PL336265A1 (es) |
SK (1) | SK140099A3 (es) |
TR (1) | TR199902550T2 (es) |
WO (1) | WO1998046604A1 (es) |
ZA (1) | ZA983175B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001057040A1 (en) * | 2000-02-03 | 2001-08-09 | Abbott Laboratories | 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
IL156872A0 (en) | 2001-02-12 | 2004-02-08 | Hoffmann La Roche | 6-substituted pyrido-pyrimidines |
CN107744520A (zh) * | 2017-10-25 | 2018-03-02 | 南京多宝生物科技有限公司 | 嘧啶类化合物在制备促进小肠蠕动药物中的应用 |
CN112209924B (zh) * | 2019-07-09 | 2022-04-05 | 中国科学院天津工业生物技术研究所 | 选择性腺苷a1受体拮抗剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB774094A (en) * | 1953-01-02 | 1957-05-08 | Wellcome Found | Improvements in or relating to pyrimidine compounds |
IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
-
1998
- 1998-04-13 HU HU0001443A patent/HUP0001443A3/hu unknown
- 1998-04-13 CA CA002286592A patent/CA2286592A1/en not_active Abandoned
- 1998-04-13 IL IL13161798A patent/IL131617A0/xx unknown
- 1998-04-13 TR TR1999/02550T patent/TR199902550T2/xx unknown
- 1998-04-13 EP EP98918091A patent/EP0975633A1/en not_active Withdrawn
- 1998-04-13 BR BR9809056-9A patent/BR9809056A/pt not_active IP Right Cessation
- 1998-04-13 JP JP54408398A patent/JP2001520654A/ja active Pending
- 1998-04-13 KR KR1019997009552A patent/KR20010006462A/ko not_active Application Discontinuation
- 1998-04-13 SK SK1400-99A patent/SK140099A3/sk unknown
- 1998-04-13 WO PCT/US1998/007201 patent/WO1998046604A1/en not_active Application Discontinuation
- 1998-04-13 NZ NZ337125A patent/NZ337125A/en unknown
- 1998-04-13 PL PL98336265A patent/PL336265A1/xx unknown
- 1998-04-13 CN CN98804117A patent/CN1252069A/zh active Pending
- 1998-04-13 AU AU71080/98A patent/AU741033B2/en not_active Ceased
- 1998-04-15 ZA ZA983175A patent/ZA983175B/xx unknown
- 1998-04-15 AR ARP980101734A patent/AR012437A1/es unknown
- 1998-04-16 CO CO98020978A patent/CO4940470A1/es unknown
-
1999
- 1999-10-15 NO NO995035A patent/NO995035L/no not_active Application Discontinuation
- 1999-11-03 BG BG103853A patent/BG103853A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR20010006462A (ko) | 2001-01-26 |
SK140099A3 (en) | 2000-05-16 |
JP2001520654A (ja) | 2001-10-30 |
ZA983175B (en) | 1998-10-21 |
AU7108098A (en) | 1998-11-11 |
HUP0001443A2 (hu) | 2000-10-28 |
NZ337125A (en) | 2001-06-29 |
WO1998046604A1 (en) | 1998-10-22 |
CN1252069A (zh) | 2000-05-03 |
CA2286592A1 (en) | 1998-10-22 |
TR199902550T2 (xx) | 2000-04-21 |
HUP0001443A3 (en) | 2001-01-29 |
NO995035D0 (no) | 1999-10-15 |
AU741033B2 (en) | 2001-11-22 |
BR9809056A (pt) | 2000-08-01 |
PL336265A1 (en) | 2000-06-19 |
CO4940470A1 (es) | 2000-07-24 |
NO995035L (no) | 1999-12-15 |
BG103853A (en) | 2000-06-30 |
IL131617A0 (en) | 2001-01-28 |
EP0975633A1 (en) | 2000-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT100631A (pt) | Antagonistas biciclicos de fibrinogenio, seu uso e composicoes farmaceuticas que os contem | |
ES2059602T3 (es) | Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral. | |
CA2098076A1 (en) | Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates | |
RU2004130488A (ru) | Пиримидиновые производные | |
UY25225A1 (es) | Derivados de pleuromutilina utiles como agentes antimicrobianos | |
RU94016183A (ru) | Производные пиперазина | |
AR012436A1 (es) | Compuestos de 4-aminopirido[2,3-d]pirimidina 5,7-disustituidos, composicion farmaceutica que los comprende, el uso de los mismos para lamanufactura de medicamentos, un procedimiento para su preparacion. | |
OA09454A (fr) | Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
ES2046193T3 (es) | Un procedimiento para la preparacion de un compuesto de imidazolidinona. | |
AR012437A1 (es) | Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacion | |
AR040233A1 (es) | Polimorfos inhibidores de xantina fosfodiesterasa v | |
EA200100597A2 (ru) | Новые 1,1- и 1,2-дизамещенные циклопропановые соединения, способ их получения и содержащие их фармацевтические композиции | |
AR012435A1 (es) | Compuesto de 4-aminopirido[2,3-d]pirimidina 6,7-disustituida; el uso del mismo para la manufactura de un medicamento, procedimiento para su preparacion,composicion farmaceutica que lo contiene, compuestos intermediarios y procedimiento para su preparacion. | |
ATE144423T1 (de) | Therapeutische benzazepin verbindungen | |
MX9300423A (es) | Derivados heterociclicos. | |
RU96102846A (ru) | Производные изохинолина в качестве терапевтических средств | |
NZ222045A (en) | From diamides up to tetrapeptides for use as anticanvulsants | |
ES477257A1 (es) | Un procedimiento para preprarar derivados de isoquinoleina. | |
RU2021107688A (ru) | Трициклические соединения, действующие на белки crbn | |
UY28119A1 (es) | Nuevos derivados que contienen fosforo | |
KR970706258A (ko) | 4a-아릴데카히드로이소키노린 화합물 및 그 의약 용도(4a-ARYLDECAHYDROISOQUINOLIN COMPOUND AND MEDICINAL USE OF THE SAME) | |
AR030196A1 (es) | Compuesto que contiene cadena lateral carbociclica, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento | |
GB1455617A (en) | Pyran derivatives | |
TH13800A (th) | อนุพันธ์ชนิดใหม่ของเพพไทด์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |